Related Experiment Video
Updated: May 15, 2026
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
Regulation of miR106b cluster through the RB pathway: mechanism and functional targets
Chellappagounder Thangavel1, Ettickan Boopathi, Adam Ertel
1Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Abstract:
The RB pathway plays a critical role in proliferation control that is commonly subverted in tumor development. However, restoration of RB pathway function can be elicited in many tumor cells by the inhibition of CDK4/6 activity that leads to dephosphorylation of RB and subsequent repression of E2F-mediated transcription. In this context, active RB/E2F complexes inhibit the expression of a critical program of coding genes that promote cell cycle progression. However, the non-coding RNA target genes downstream from RB that could be relevant for tumor biology remain obscure. Here, miRNA gene expression profiling identified the miR106b cluster as being efficiently repressed with CDK4/6 inhibition in an E2F and RB-dependent manner. Importantly, the miR106B-cluster is intragenic of MCM7, and through a series of functional studies, the basis of MCM7 regulation and concordant expression of the miRNA species within the 106b cluster was determined. Importantly, RB-mediated repression of the 106b cluster enhances the transcript levels of p21Cip1 and PTEN. These data provide a mechanistic basis for cross-talk between the RB pathway and p21 and PTEN through the regulation of the MCM7/miR106b locus.
Insights
Inhibition of CDK4/6 restores RB pathway function, repressing the miR106b cluster. This RB-mediated repression enhances p21Cip1 and PTEN levels, revealing a novel regulatory mechanism in tumor biology.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genetics
Background:
- The Retinoblastoma (RB) pathway is crucial for controlling cell proliferation and is frequently disrupted in cancer.
- Inhibiting Cyclin-Dependent Kinase 4/6 (CDK4/6) can restore RB pathway function, leading to cell cycle arrest.
- While RB's role in regulating coding genes is known, its impact on non-coding RNA targets in tumors is less understood.
Purpose of the Study:
- To identify non-coding RNA target genes regulated by the RB pathway.
- To investigate the role of the miR106b cluster in RB pathway-mediated tumor suppression.
- To elucidate the regulatory relationship between MCM7, the miR106b cluster, and tumor suppressor genes.
Main Methods:
- MicroRNA (miRNA) gene expression profiling to identify RB-regulated miRNAs.
- Functional studies to determine the regulation of the MCM7 gene and miR106b cluster.
- Analysis of transcript levels of p21Cip1 and PTEN in response to RB pathway modulation.
Main Results:
- The miR106b cluster was identified as being repressed in an RB and E2F-dependent manner upon CDK4/6 inhibition.
- The miR106b cluster is located within the MCM7 gene, and its expression is concordant with MCM7.
- RB-mediated repression of the miR106b cluster leads to increased expression of p21Cip1 and PTEN.
Conclusions:
- The study reveals a novel mechanism where RB pathway regulation of the MCM7/miR106b locus influences tumor suppressor gene expression.
- This provides a mechanistic link between RB pathway activity and the regulation of p21Cip1 and PTEN via non-coding RNAs.
- Understanding this cross-talk offers potential therapeutic strategies targeting the RB pathway in cancer treatment.
Related Concept Videos
01:23Negative Regulator Molecules
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:23Abnormal Proliferation
01:23Regulation of Expression at Multiple Steps
01:22MicroRNAs
01:22MicroRNAs